RichardMichaelZunigaMD

Oncology • Babylon, NY

Hematologic Oncology, Neuro-Oncology

Physician

Join to view full profile

Dr. Zuniga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zuniga's full profile

Already have an account?

Office
72 E Main St Ste 1
Babylon, NY 11702
Phone+1 631-751-3000

Fax+1 978-788-7966

Summary

Dr. Richard Zuniga is an oncologist in Babylon, NY and is affiliated with multiple hospitals in the area. He received his medical degree from University of San Martin de Porres. He specializes in hematology-oncology, neuro-oncology with a fellowship in Drug Development. He is the medical chief of research at NY Cancer and blood specialists conducting over 40 industry sponsored clinical trials.

Education & Training

The University of Texas Health Science Center at San AntonioOncology, Drug Development, 2010 - 2012
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
Henry Ford Hermelin Brain Tumor CenterNeuro-oncology, Fellowship , 2007 - 2008
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2004 - 2007
University of San Martin de Porres Faculty of MedicineClass of 2003

Certifications & Licensure

NY State Medical License 2012 - 2026
MA State Medical License 2015 - 2020
TX State Medical License 2011 - 2013
MI State Medical License 2004 - 2011
American Board of Internal Medicine Medical Oncology

Clinical Trials

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2023 Jun 30
Recruiting
Phase 2, Phase 3
First-in-Human Study of RGT-419B Alone and With Endocrine Therapy in Subjects With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Start of enrollment: 2022 Mar 04
Recruiting
Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer Start of enrollment: 2023 Jan 24
Recruiting
Phase 1, Phase 2
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. Start of enrollment: 2023 Dec 05
Recruiting
Phase 3
A Trial Assessing Chemo Mouthpiece Device With Best Supportive Care for Symptoms of Chemotherapy-Induced Oral Mucositis Start of enrollment: 2020 Aug 31
Completed
Not Applicable
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer Start of enrollment: 2022 Jul 25
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in...
Gregory A Vidal, Neha Jain, Aaron Fisher, Daniel Sheinson, Katherine T Lofgren
JCO Oncology Practice. 2024-03-01
23 citations
Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study.
Andrew Brenner, Richard Zuniga, Jessica D Sun, John Floyd, Charles P. Hart
Neuro-Oncology. 2018-08-02
50 citations
Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma
William T. Phillips, Beth A. Goins, Ande Bao, Daniel Vargas, Juan E. Guttierez
Neuro-Oncology. 2012-04-01

Research History

Medical Chief of ResearchNew York Cancer and Blood specialists Conducting over 40 clinical trials2021 - Present

Other Languages

Spanish